專利是企業對於風險高且成本高的研發投資所得到的回報，故而所投資的專利資產可能蘊含著企業價值。本研究分別從智財角度以及財務角度檢驗 25 家基因檢測公司的專利風險指標與企業價值之間的關係。基於相關文獻，本研究假設托賓 Q 作為企業價值的代理指標，並假設在 (1) 技術糾紛、 (2) 技術質量或 (3) 技術市場維度的專利風險相關指標會影響企業價值。本研究還考慮了內部控制變量對公司價值績效的影響。在對專利風險指標使用多元量化迴歸方法和穩健性測試後得到的實證結果發現，專利風險指標於基因檢測行業的企業價值上有顯著關係。

Patents are the returns of risky and costly R&D investments for the company; thus the invested patent assets may imply the firm value. This study employs an intellectual perspective and a financial perspective to examine the relationship between patent risk indicators and corporate value in 25 Genetics testing companies. Based on the relevant literature, the study hypothesized that Tobin’s Q as a proxy measures for the firm value, and the patent risk related indicators in (1) technical disputes, (2) technical quality or (3) technical market dimensions impact the firm value. This study also takes into account the influence of internal control variables on the performance of firm value. The empirical results drawn for patent risk indicators using multiple quantitative regressions and robust testing find significant differences in corporate value of the genetic testing industry.

李玉梅 (2005)，「高科技產業專利風險管理機制之探討―以專利保險為例」，碩士論文，中原大學財經法律研究所。
張鎮堃 (2019)，「創新存量及專利策略對廠商營運績效之影響―以台灣半導體產業為例」，碩士論文，國立中山大學經濟學研究所。
鄭証元 (2021)，「專利訴訟風險的實證研究」，博士論文，國立臺灣大學管理學院資訊管理學系。
Allison, J. R., Lemley, M. A., Moore, K. A., & Trunkey, R. D. (2003). Valuable patents. Geo. Lj, 92, 435.
Bliese, P. D. (2000). Within-group agreement, non-independence, and reliability: Implications for data aggregation and analysis.
Chin, C.-L., Lee, P., Chi, H.-Y., & Anandarajan, A. (2006). Patent citation, R&D spillover, and Tobin's Q: evidence from Taiwan semiconductor industry. Review of Quantitative Finance and Accounting, 26(1), 67-84.
Cooper, D. R. and Schindler, P. S. (2003). Business Research Methods (8th Edition). Boston: Mcgraw-hill Irwin.
Ewens, M., Peters, R. H., & Wang, S. (2019). Measuring intangible capital with market prices (No. w25960). National Bureau of Economic Research.
Gleason, K. I., & Klock, M. (2006). Intangible capital in the pharmaceutical and chemical industry. The Quarterly Review of Economics and Finance, 46(2), 300-314.
Hagedoorn, J., & Cloodt, M. (2003). Measuring innovative performance: is there an advantage in using multiple indicators? Research Policy, 32(8), 1365-1379.
Hagelin, T. (2003). Valuation of patent licenses. Tex. Intell. Prop. LJ, 12, 423.
Hall, B. H., Thoma, G., & Torrisi, S. (2007). The market value of patents and R&D: Evidence from European Firms. Paper presented at the Academy of Management Proceedings.
Hsieh, C.-H. (2013). Patent value assessment and commercialization strategy. Technological forecasting and Social Change, 80(2), 307-319.
Lanjouw, J. O., & Schankerman, M. (2004). Patent quality and research productivity: Measuring innovation with multiple indicators. The Economic Journal, 114(495), 441-465.
Lev, B., & Zarowin, P. (1999). The boundaries of financial reporting and how to extend them. Journal of Accounting research, 37(2), 353-385.
Lin, B. W., & Chen, J. S. (2005). Corporate technology portfolios and R&D performance measures: a study of technology intensive firms. R&D Management, 35(2), 157-170.
McNichols, M., Rajan, M. V., & Reichelstein, S. (2014). Conservatism correction for the market-to-book ratio and Tobin’sq. Review of Accounting Studies, 19(4), 1393-1435.
Megna, P., & Klock, M. (1993). The impact of intangible capital on Tobin's q in the semiconductor industry. The American Economic Review, 83(2), 265-269.
Olajide, O. S., Funmi, S. R., & O. Olayemi, S.-O. (2017). Capital structure-firm performance relationship: Empirical evidence from African countries. Journal of Emerging Trends in Economics and Management Sciences, 8(2), 82-95.
Pakes, A., & Griliches, Z. (1980). Patents and R&D at the firm level: A first report. Economics Letters, 5(4), 377-381.
Peters, R. H., & Taylor, L. A. (2017). Intangible capital and the investment-q relation. Journal of Financial Economics, 123(2), 251-272.
Rajan, R. G., & Zingales, L. (1995). What do we know about capital structure? Some evidence from international data. The Journal of Finance, 50(5), 1421-1460.
Rao, V. R., Agarwal, M. K., & Dahlhoff, D. (2004). How is manifest branding strategy related to the intangible value of a corporation? Journal of Marketing, 68(4), 126-141.
Roychowdhury, S., & Watts, R. L. (2007). Asymmetric timeliness of earnings, market-to-book and conservatism in financial reporting. Journal of Accounting and Economics, 44(1-2), 2-31.
Shane, H., & Klock, M. (1997). The relation between patent citations and Tobin's Q in the semiconductor industry. Review of Quantitative Finance and Accounting, 9(2), 131-146.
Smith Jr, C. W., & Watts, R. L. (1992). The investment opportunity set and corporate financing, dividend, and compensation policies. Journal of FinancialEeconomics, 32(3), 263-292.
Tseng, C. Y., & James Goo, Y. J. (2005). Intellectual capital and corporate value in an emerging economy: empirical study of Taiwanese manufacturers. R&D Management, 35(2), 187-201.
Woeppel, M. (2021). Using Patent Capital to Estimate Tobin's q. Available at SSRN 3420322.
Yermack, D. (1995). Do corporations award CEO stock options effectively? Journal of FinancialEeconomics, 39(2-3), 237-269.
Zhang, L. Y., & Toffanin, M. (2018). The information environment of the firm and the market valuation of R&D. Journal of Business Finance & Accounting, 45(9-10), 1051-1081.